Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial.

Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial.

Dysbalance in gut microbiota has been linked to increased microbial translocation, leading to chronic inflammation in HIV-patients, even under effective HAART. Moreover, microbial translocation is associated with insufficient reconstitution of CD4+T cells, and contributes to the pathogenesis of immu...

Full description

Bibliographic Details
Main Authors: Judit Villar-García, Robert Güerri-Fernández, Andrés Moya, Alicia González, Juan J Hernández, Elisabet Lerma, Ana Guelar, Luisa Sorli, Juan P Horcajada, Alejandro Artacho, Giuseppe D Auria, Hernando Knobel
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5384743?pdf=render

Internet

http://europepmc.org/articles/PMC5384743?pdf=render

Similar Items